Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 20, 2011

View Archived Issues

FDA approves Oxford BioMedica's IND for UshStat trial

Exparel leads to sustained release of bupivacaine

Lilly begins phase II study of LY-2510924 in SCLC

New carbazole-linked hybrid antitumor agents prepared

Servier and Miragen enter research partnership for microRNA-targeted drugs

BeiGene in-licenses two clinical-stage oncology candidates

Ampio Pharmaceuticals reports clinical data on intranasal danazol

AstraZeneca and Forest Laboratories advance antibiotic combination CAZ-AVI

Vandetanib/bicalutamide combination trial does not meet primary endpoint

Phase II study assessed combination therapy containing rilotumumab in cancer

Korean scientists identify serum biomarkers of preeclampsia

Brazilian university designs new analgesic with in vivo activity

Clinical data analyses examine efficacy and safety of lorcaserin

Scientists at Prosidion prepare new ghrelin receptor ligands

Wisconsin Alumni Research Foundation patents new ligands of vitamin D receptor

Novel agents for HCV infection disclosed by Vertex

New protein kinase inhibitors presented by GSK

Abbott to split into two companies

Vertex submits Kalydeco NDA for priority review

Viralytics begins enrollment in phase II Cavatak trial following approval for dosing

FDA approves new indication for Byetta

FDA opens Cleveland BioLabs' IND for CBLB-502

Augment bone graft approved in Australia

Genticel completes recruitment in HPV vaccine trial

Syntaxin and Ipsen enter new global discovery and development collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...